Connecticut Reporting Transparency Updates In 2018, Connecticut established the Office of Health Strategy (OHS) with a clear mission: to implement...

New Mexico Passes Prescription Drug Price Transparency Act New Bill: HB0033AFS (nmlegis.gov)  Effective: 01/01/2025 The new bill, titled the...

Supreme Court Ruling  on Chevron Deference Threatens to Reshape the Regulatory Landscape The Chevron v. Natural Resources Defense Council (NRDC)...

Veteran’s Health Administration Announces New Trading Partner Requirements  The Veteran’s Health Administration announced new requirements that...

Regulatory Recap of New State & Federal Regulations In the dynamic landscape of pharmaceutical regulation, staying informed about the latest...

Third Florida Development Paints a Clear Target on Pharma Pricing  Three major regulatory developments in Florida in the past six months paint a...

State and Federal Regulatory Changes for Early January 2024  As we begin our 2024 regulatory journey, state and federal regulations haven’t slowed...

      Written by: Sumeet Singh | Founder & CEO   12/7/2023 Hello Everyone, It’s been an incredibly successful, and sometimes challenging,...

      Written by: Sumeet Singh | Chief Executive Officer   The FTC is taking names and grabbing headlines this fall, as they have unveiled...

      Written by: Joe Rizzo | Chief Marketing Officer   LighthouseAI has prioritized accumulating expansive pharmaceutical supply chain...

      Written by: Deneen Fumich | RPh & Director of Strategic Affairs   Illinois has revised requirements for licensed pharmacies (resident...

Written by: Sumeet Singh | Chief Executive Officer   Introduction  In the ever-evolving world of pharmaceutical regulations, the Alabama Board...